{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T13:52:11Z","timestamp":1776693131380,"version":"3.51.2"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T00:00:00Z","timestamp":1731369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T00:00:00Z","timestamp":1731369600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-77416-4","type":"journal-article","created":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T08:17:30Z","timestamp":1731399450000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["A predicted epithelial-to-mesenchymal transition-associated mRNA\/miRNA axis contributes to the progression of diabetic liver disease"],"prefix":"10.1038","volume":"14","author":[{"given":"Alina-Veronica","family":"Ghionescu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrei","family":"Sorop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ekaterini","family":"Linioudaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristin","family":"Coman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorand","family":"Savu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marton","family":"Fogarasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Lixandru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simona Olimpia","family":"Dima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,11,12]]},"reference":[{"key":"77416_CR1","doi-asserted-by":"publisher","first-page":"101636","DOI":"10.1016\/j.pmedr.2021.101636","volume":"25","author":"ME Singer","year":"2022","unstructured":"Singer, M. E., Dorrance, K. A., Oxenreiter, M. M., Yan, K. R. & Close, K. L. The type 2 diabetes \u2018modern preventable pandemic\u2019 and replicable lessons from the COVID-19 crisis. Prev. Med. Rep. 25, 101636. https:\/\/doi.org\/10.1016\/j.pmedr.2021.101636 (2022).","journal-title":"Prev. Med. Rep."},{"key":"77416_CR2","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41574-020-0355-7","volume":"16","author":"DL Eizirik","year":"2020","unstructured":"Eizirik, D. L., Pasquali, L. & Cnop, M. Pancreatic beta-cells in type 1 and type 2 diabetes mellitus: different pathways to failure. Nat. Rev. Endocrinol. 16, 349\u2013362. https:\/\/doi.org\/10.1038\/s41574-020-0355-7 (2020).","journal-title":"Nat. Rev. Endocrinol."},{"key":"77416_CR3","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1007\/s00125-020-05176-7","volume":"63","author":"R Mallone","year":"2020","unstructured":"Mallone, R. & Eizirik, D. L. Presumption of innocence for beta cells: why are they vulnerable autoimmune targets in type 1 diabetes? Diabetologia. 63, 1999\u20132006. https:\/\/doi.org\/10.1007\/s00125-020-05176-7 (2020).","journal-title":"Diabetologia"},{"key":"77416_CR4","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1001\/jama.2020.2298","volume":"323","author":"AC Sheka","year":"2020","unstructured":"Sheka, A. C. et al. Nonalcoholic steatohepatitis: a review. JAMA. 323, 1175\u20131183. https:\/\/doi.org\/10.1001\/jama.2020.2298 (2020).","journal-title":"JAMA"},{"key":"77416_CR5","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","volume":"77","author":"ZM Younossi","year":"2023","unstructured":"Younossi, Z. M. et al. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. Hepatology. 77, 1335\u20131347. https:\/\/doi.org\/10.1097\/HEP.0000000000000004 (2023).","journal-title":"Hepatology"},{"key":"77416_CR6","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1007\/s12072-023-10620-y","volume":"18","author":"MM Ramirez-Mejia","year":"2024","unstructured":"Ramirez-Mejia, M. M., Jimenez-Gutierrez, C., Eslam, M. & George, J. Mendez-Sanchez, N. Breaking new ground: MASLD vs. MAFLD-which holds the key for risk stratification? Hepatol. Int. 18, 168\u2013178. https:\/\/doi.org\/10.1007\/s12072-023-10620-y (2024).","journal-title":"Hepatol. Int."},{"key":"77416_CR7","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1002\/hep.29466","volume":"67","author":"C Estes","year":"2018","unstructured":"Estes, C., Razavi, H., Loomba, R., Younossi, Z. & Sanyal, A. J. Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease. Hepatology. 67, 123\u2013133. https:\/\/doi.org\/10.1002\/hep.29466 (2018).","journal-title":"Hepatology"},{"key":"77416_CR8","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3350\/cmh.2022.0095","volume":"29","author":"T Nakatsuka","year":"2023","unstructured":"Nakatsuka, T. & Tateishi, R. Development and prognosis of hepatocellular carcinoma in patients with diabetes. Clin. Mol. Hepatol. 29, 51\u201364. https:\/\/doi.org\/10.3350\/cmh.2022.0095 (2023).","journal-title":"Clin. Mol. Hepatol."},{"key":"77416_CR9","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1002\/hep.32542","volume":"77","author":"PA Shah","year":"2023","unstructured":"Shah, P. A., Patil, R. & Harrison, S. A. NAFLD-related hepatocellular carcinoma: the growing challenge. Hepatology. 77, 323\u2013338. https:\/\/doi.org\/10.1002\/hep.32542 (2023).","journal-title":"Hepatology"},{"key":"77416_CR10","doi-asserted-by":"publisher","first-page":"100811","DOI":"10.1016\/j.jhepr.2023.100811","volume":"5","author":"S Talamantes","year":"2023","unstructured":"Talamantes, S. et al. Non-alcoholic fatty liver disease and diabetes mellitus as growing aetiologies of hepatocellular carcinoma. JHEP Rep. 5, 100811. https:\/\/doi.org\/10.1016\/j.jhepr.2023.100811 (2023).","journal-title":"JHEP Rep."},{"key":"77416_CR11","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1038\/s42255-021-00393-9","volume":"3","author":"JA Wali","year":"2021","unstructured":"Wali, J. A. et al. Impact of dietary carbohydrate type and protein-carbohydrate interaction on metabolic health. Nat. Metab. 3, 810\u2013828. https:\/\/doi.org\/10.1038\/s42255-021-00393-9 (2021).","journal-title":"Nat. Metab."},{"key":"77416_CR12","doi-asserted-by":"publisher","first-page":"737759","DOI":"10.3389\/fmed.2021.737759","volume":"8","author":"R Villani","year":"2021","unstructured":"Villani, R. et al. Genetic polymorphisms and clinical features in Diabetic patients with fatty liver: results from a single-center experience in Southern Italy. Front. Med. (Lausanne). 8, 737759. https:\/\/doi.org\/10.3389\/fmed.2021.737759 (2021).","journal-title":"Front. Med. (Lausanne)"},{"key":"77416_CR13","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/nrendo.2017.80","volume":"13","author":"MC Petersen","year":"2017","unstructured":"Petersen, M. C., Vatner, D. F. & Shulman, G. I. Regulation of hepatic glucose metabolism in health and disease. Nat. Rev. Endocrinol. 13, 572\u2013587. https:\/\/doi.org\/10.1038\/nrendo.2017.80 (2017).","journal-title":"Nat. Rev. Endocrinol."},{"key":"77416_CR14","doi-asserted-by":"publisher","first-page":"50","DOI":"10.15420\/ecr.2018.33.1","volume":"14","author":"S Tsalamandris","year":"2019","unstructured":"Tsalamandris, S. et al. The role of inflammation in diabetes: current concepts and future perspectives. Eur. Cardiol. 14, 50\u201359. https:\/\/doi.org\/10.15420\/ecr.2018.33.1 (2019).","journal-title":"Eur. Cardiol."},{"key":"77416_CR15","doi-asserted-by":"publisher","first-page":"110413","DOI":"10.1016\/j.biopha.2020.110413","volume":"129","author":"Y Chen","year":"2020","unstructured":"Chen, Y. et al. Study on the relationship between hepatic fibrosis and epithelial-mesenchymal transition in intrahepatic cells. Biomed. Pharmacother. 129, 110413. https:\/\/doi.org\/10.1016\/j.biopha.2020.110413 (2020).","journal-title":"Biomed. Pharmacother"},{"key":"77416_CR16","doi-asserted-by":"publisher","first-page":"23337","DOI":"10.1074\/jbc.M700194200","volume":"282","author":"M Zeisberg","year":"2007","unstructured":"Zeisberg, M. et al. Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition. J. Biol. Chem. 282, 23337\u201323347. https:\/\/doi.org\/10.1074\/jbc.M700194200 (2007).","journal-title":"J. Biol. Chem."},{"key":"77416_CR17","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41580-020-0237-9","volume":"21","author":"J Yang","year":"2020","unstructured":"Yang, J. et al. Guidelines and definitions for research on epithelial-mesenchymal transition. Nat. Rev. Mol. Cell. Biol. 21, 341\u2013352. https:\/\/doi.org\/10.1038\/s41580-020-0237-9 (2020).","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"77416_CR18","doi-asserted-by":"publisher","unstructured":"Kwapisz, O. et al. Fatty acids and a high-Fat Diet induce epithelial-mesenchymal transition by activating TGFbeta and beta-catenin in liver cells. Int. J. Mol. Sci. 22 https:\/\/doi.org\/10.3390\/ijms22031272 (2021).","DOI":"10.3390\/ijms22031272"},{"key":"77416_CR19","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.cell.2009.11.007","volume":"139","author":"JP Thiery","year":"2009","unstructured":"Thiery, J. P., Acloque, H., Huang, R. Y. & Nieto, M. A. Epithelial-mesenchymal transitions in development and disease. Cell. 139, 871\u2013890. https:\/\/doi.org\/10.1016\/j.cell.2009.11.007 (2009).","journal-title":"Cell"},{"key":"77416_CR20","doi-asserted-by":"publisher","unstructured":"Angelescu, M. A. et al. miRNAs as biomarkers in diabetes: moving towards Precision Medicine. Int. J. Mol. Sci. 23 https:\/\/doi.org\/10.3390\/ijms232112843 (2022).","DOI":"10.3390\/ijms232112843"},{"key":"77416_CR21","doi-asserted-by":"publisher","first-page":"1270425","DOI":"10.3389\/fphar.2023.1270425","volume":"14","author":"AV Ghionescu","year":"2023","unstructured":"Ghionescu, A. V., Sorop, A. & Dima, S. O. The pivotal role of EMT-related noncoding RNAs regulatory axes in hepatocellular carcinoma. Front. Pharmacol. 14, 1270425. https:\/\/doi.org\/10.3389\/fphar.2023.1270425 (2023).","journal-title":"Front. Pharmacol."},{"key":"77416_CR22","doi-asserted-by":"publisher","unstructured":"Dudas, J., Ladanyi, A., Ingruber, J., Steinbichler, T. B. & Riechelmann, H. Epithelial to mesenchymal transition: a mechanism that fuels Cancer Radio\/Chemoresistance. Cells. 9 https:\/\/doi.org\/10.3390\/cells9020428 (2020).","DOI":"10.3390\/cells9020428"},{"key":"77416_CR23","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1093\/bioinformatics\/btm254","volume":"23","author":"S Davis","year":"2007","unstructured":"Davis, S. & Meltzer, P. S. GEOquery: a bridge between the Gene expression Omnibus (GEO) and BioConductor. Bioinformatics. 23, 1846\u20131847. https:\/\/doi.org\/10.1093\/bioinformatics\/btm254 (2007).","journal-title":"Bioinformatics"},{"key":"77416_CR24","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of Fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550. https:\/\/doi.org\/10.1186\/s13059-014-0550-8 (2014).","journal-title":"Genome Biol."},{"key":"77416_CR25","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon, A. et al. The Molecular signatures database (MSigDB) hallmark gene set collection. Cell. Syst. 1, 417\u2013425. https:\/\/doi.org\/10.1016\/j.cels.2015.12.004 (2015).","journal-title":"Cell. Syst."},{"key":"77416_CR26","doi-asserted-by":"publisher","first-page":"3170","DOI":"10.1038\/sj.onc.1209083","volume":"25","author":"J Gotzmann","year":"2006","unstructured":"Gotzmann, J. et al. A crucial function of PDGF in TGF-beta-mediated cancer progression of hepatocytes. Oncogene. 25, 3170\u20133185. https:\/\/doi.org\/10.1038\/sj.onc.1209083 (2006).","journal-title":"Oncogene"},{"key":"77416_CR27","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/s41416-020-01178-9","volume":"124","author":"SV Vasaikar","year":"2021","unstructured":"Vasaikar, S. V. et al. EMTome: a resource for pan-cancer analysis of epithelial-mesenchymal transition genes and signatures. Br. J. Cancer. 124, 259\u2013269. https:\/\/doi.org\/10.1038\/s41416-020-01178-9 (2021).","journal-title":"Br. J. Cancer"},{"key":"77416_CR28","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.cmet.2010.09.015","volume":"12","author":"H Misu","year":"2010","unstructured":"Misu, H. et al. A liver-derived secretory protein, selenoprotein P, causes insulin resistance. Cell. Metab. 12, 483\u2013495. https:\/\/doi.org\/10.1016\/j.cmet.2010.09.015 (2010).","journal-title":"Cell. Metab."},{"key":"77416_CR29","doi-asserted-by":"publisher","first-page":"32607","DOI":"10.18632\/oncotarget.8927","volume":"7","author":"G Liu","year":"2016","unstructured":"Liu, G. et al. Potential diagnostic and prognostic marker dimethylglycine dehydrogenase (DMGDH) suppresses hepatocellular carcinoma metastasis in vitro and in vivo. Oncotarget. 7, 32607\u201332616. https:\/\/doi.org\/10.18632\/oncotarget.8927 (2016).","journal-title":"Oncotarget"},{"key":"77416_CR30","doi-asserted-by":"publisher","first-page":"e133","DOI":"10.1093\/nar\/gku631","volume":"42","author":"Y Ru","year":"2014","unstructured":"Ru, Y. et al. The multiMiR R package and database: integration of microRNA-target interactions along with their disease and drug associations. Nucleic Acids Res. 42, e133. https:\/\/doi.org\/10.1093\/nar\/gku631 (2014).","journal-title":"Nucleic Acids Res."},{"key":"77416_CR31","doi-asserted-by":"publisher","first-page":"W244","DOI":"10.1093\/nar\/gkaa467","volume":"48","author":"L Chang","year":"2020","unstructured":"Chang, L., Zhou, G., Soufan, O. & Xia, J. miRNet 2.0: network-based visual analytics for miRNA functional analysis and systems biology. Nucleic Acids Res. 48, W244\u2013W251. https:\/\/doi.org\/10.1093\/nar\/gkaa467 (2020).","journal-title":"Nucleic Acids Res."},{"key":"77416_CR32","doi-asserted-by":"publisher","first-page":"7964","DOI":"10.1073\/pnas.0405277102","volume":"102","author":"T Sapir","year":"2005","unstructured":"Sapir, T. et al. Cell-replacement therapy for diabetes: Generating functional insulin-producing tissue from adult human liver cells. Proc. Natl. Acad. Sci. U S A. 102, 7964\u20137969. https:\/\/doi.org\/10.1073\/pnas.0405277102 (2005).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"77416_CR33","doi-asserted-by":"publisher","unstructured":"Meivar-Levy, I. et al. Human liver cells expressing albumin and mesenchymal characteristics give rise to insulin-producing cells. J. Transpl. 2011 (252387). https:\/\/doi.org\/10.1155\/2011\/252387 (2011).","DOI":"10.1155\/2011\/252387"},{"key":"77416_CR34","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1038\/nprot.2008.73","volume":"3","author":"TD Schmittgen","year":"2008","unstructured":"Schmittgen, T. D. & Livak, K. J. Analyzing real-time PCR data by the comparative C(T) method. Nat. Protoc. 3, 1101\u20131108. https:\/\/doi.org\/10.1038\/nprot.2008.73 (2008).","journal-title":"Nat. Protoc."},{"key":"77416_CR35","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.2217\/fon.09.91","volume":"5","author":"F van Zijl","year":"2009","unstructured":"van Zijl, F. et al. Epithelial-mesenchymal transition in hepatocellular carcinoma. Future Oncol. 5, 1169\u20131179. https:\/\/doi.org\/10.2217\/fon.09.91 (2009).","journal-title":"Future Oncol."},{"key":"77416_CR36","doi-asserted-by":"publisher","first-page":"115683","DOI":"10.1016\/j.envres.2023.115683","volume":"227","author":"YE Alqurashi","year":"2023","unstructured":"Alqurashi, Y. E. et al. Harnessing function of EMT in hepatocellular carcinoma: from biological view to nanotechnological standpoint. Environ. Res. 227, 115683. https:\/\/doi.org\/10.1016\/j.envres.2023.115683 (2023).","journal-title":"Environ. Res."},{"key":"77416_CR37","doi-asserted-by":"publisher","unstructured":"Catalanotto, C., Cogoni, C. & Zardo, G. MicroRNA in Control of Gene expression: an overview of Nuclear functions. Int. J. Mol. Sci. 17 https:\/\/doi.org\/10.3390\/ijms17101712 (2016).","DOI":"10.3390\/ijms17101712"},{"key":"77416_CR38","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.tig.2022.02.006","volume":"38","author":"C Diener","year":"2022","unstructured":"Diener, C., Keller, A. & Meese, E. Emerging concepts of miRNA therapeutics: from cells to clinic. Trends Genet. 38, 613\u2013626. https:\/\/doi.org\/10.1016\/j.tig.2022.02.006 (2022).","journal-title":"Trends Genet."},{"key":"77416_CR39","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s43094-022-00413-9","volume":"8","author":"AN Saiyed","year":"2022","unstructured":"Saiyed, A. N., Vasavada, A. R. & Johar, S. R. K. Recent trends in miRNA therapeutics and the application of plant miRNA for prevention and treatment of human diseases. Futur J. Pharm. Sci. 8, 24. https:\/\/doi.org\/10.1186\/s43094-022-00413-9 (2022).","journal-title":"Futur J. Pharm. Sci."},{"key":"77416_CR40","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s10038-008-0279-x","volume":"53","author":"Y Ruike","year":"2008","unstructured":"Ruike, Y. et al. Global correlation analysis for micro-RNA and mRNA expression profiles in human cell lines. J. Hum. Genet. 53, 515. https:\/\/doi.org\/10.1007\/s10038-008-0279-x (2008).","journal-title":"J. Hum. Genet."},{"key":"77416_CR41","doi-asserted-by":"publisher","first-page":"33","DOI":"10.2217\/rme-2020-0093","volume":"16","author":"R Iacob","year":"2021","unstructured":"Iacob, R. et al. Phenotypic assessment of liver-derived cell cultures during in vitro expansion. Regen Med. 16, 33\u201346. https:\/\/doi.org\/10.2217\/rme-2020-0093 (2021).","journal-title":"Regen Med."},{"key":"77416_CR42","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/B978-0-12-394311-8.00014-5","volume":"116","author":"A Gheldof","year":"2013","unstructured":"Gheldof, A. & Berx, G. Cadherins and epithelial-to-mesenchymal transition. Prog Mol. Biol. Transl Sci. 116, 317\u2013336. https:\/\/doi.org\/10.1016\/B978-0-12-394311-8.00014-5 (2013).","journal-title":"Prog Mol. Biol. Transl Sci."},{"key":"77416_CR43","doi-asserted-by":"publisher","unstructured":"Loh, C. Y. et al. The E-Cadherin and N-Cadherin switch in Epithelial-To-Mesenchymal transition: signaling, therapeutic implications, and challenges. Cells. 8 https:\/\/doi.org\/10.3390\/cells8101118 (2019).","DOI":"10.3390\/cells8101118"},{"key":"77416_CR44","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1007\/s12094-016-1582-1","volume":"19","author":"L Chang","year":"2017","unstructured":"Chang, L., Li, K. & Guo, T. miR-26a-5p suppresses tumor metastasis by regulating EMT and is associated with prognosis in HCC. Clin. Transl Oncol. 19, 695\u2013703. https:\/\/doi.org\/10.1007\/s12094-016-1582-1 (2017).","journal-title":"Clin. Transl Oncol."},{"key":"77416_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13045-015-0229-y","volume":"9","author":"DN Ma","year":"2016","unstructured":"Ma, D. N. et al. MicroRNA-26a suppresses epithelial-mesenchymal transition in human hepatocellular carcinoma by repressing enhancer of zeste homolog 2. J. Hematol. Oncol. 9, 1. https:\/\/doi.org\/10.1186\/s13045-015-0229-y (2016).","journal-title":"J. Hematol. Oncol."},{"key":"77416_CR46","doi-asserted-by":"publisher","first-page":"6248","DOI":"10.1038\/srep06248","volume":"4","author":"Y Zhang","year":"2014","unstructured":"Zhang, Y. et al. MiR-424-5p reversed epithelial-mesenchymal transition of anchorage-independent HCC cells by directly targeting ICAT and suppressed HCC progression. Sci. Rep. 4, 6248. https:\/\/doi.org\/10.1038\/srep06248 (2014).","journal-title":"Sci. Rep."},{"key":"77416_CR47","doi-asserted-by":"publisher","unstructured":"Ali, O., Darwish, H. A., Eldeib, K. M. & Abdel Azim, S. A. miR-26a potentially contributes to the regulation of fatty acid and sterol metabolism in Vitro Human HepG2 Cell Model of nonalcoholic fatty liver disease. Oxid. Med. Cell. Longev. 2018 (8515343). https:\/\/doi.org\/10.1155\/2018\/8515343 (2018).","DOI":"10.1155\/2018\/8515343"},{"key":"77416_CR48","doi-asserted-by":"publisher","first-page":"e0242179","DOI":"10.1371\/journal.pone.0242179","volume":"15","author":"Y Zhao","year":"2020","unstructured":"Zhao, Y. et al. MiR-424-5p regulates cell cycle and inhibits proliferation of hepatocellular carcinoma cells by targeting E2F7. PLoS One. 15, e0242179. https:\/\/doi.org\/10.1371\/journal.pone.0242179 (2020).","journal-title":"PLoS One"},{"key":"77416_CR49","doi-asserted-by":"publisher","first-page":"773","DOI":"10.3350\/cmh.2021.0383","volume":"28","author":"HS Shin","year":"2022","unstructured":"Shin, H. S., Jun, B. G. & Yi, S. W. Impact of diabetes, obesity, and dyslipidemia on the risk of hepatocellular carcinoma in patients with chronic liver diseases. Clin. Mol. Hepatol. 28, 773\u2013789. https:\/\/doi.org\/10.3350\/cmh.2021.0383 (2022).","journal-title":"Clin. Mol. Hepatol."},{"key":"77416_CR50","doi-asserted-by":"publisher","unstructured":"Zunica, E. R. M., Heintz, E. C., Axelrod, C. L. & Kirwan, J. P. Obesity Management in the Primary Prevention of Hepatocellular Carcinoma. Cancers (Basel). 14. https:\/\/doi.org\/10.3390\/cancers14164051 (2022).","DOI":"10.3390\/cancers14164051"},{"key":"77416_CR51","doi-asserted-by":"publisher","first-page":"194","DOI":"10.3892\/etm.2020.9324","volume":"20","author":"R Albulescu","year":"2020","unstructured":"Albulescu, R. et al. COVID-19 and diabetes mellitus: unraveling the hypotheses that worsen the prognosis (review). Exp. Ther. Med. 20, 194. https:\/\/doi.org\/10.3892\/etm.2020.9324 (2020).","journal-title":"Exp. Ther. Med."},{"key":"77416_CR52","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1007\/s10637-016-0407-y","volume":"35","author":"MS Beg","year":"2017","unstructured":"Beg, M. S. et al. Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors. Invest. New. Drugs. 35, 180\u2013188. https:\/\/doi.org\/10.1007\/s10637-016-0407-y (2017).","journal-title":"Invest. New. Drugs"},{"key":"77416_CR53","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1111\/j.1440-1746.2011.06847.x","volume":"27","author":"DQ Zhan","year":"2012","unstructured":"Zhan, D. Q. et al. Reduced N-cadherin expression is associated with metastatic potential and poor surgical outcomes of hepatocellular carcinoma. J. Gastroenterol. Hepatol. 27, 173\u2013180. https:\/\/doi.org\/10.1111\/j.1440-1746.2011.06847.x (2012).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"77416_CR54","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1111\/j.1440-1746.2007.05182.x","volume":"23","author":"DD Seo","year":"2008","unstructured":"Seo, D. D. et al. Neural cadherin overexpression is a predictive marker for early postoperative recurrence in hepatocellular carcinoma patients. J. Gastroenterol. Hepatol. 23, 1112\u20131118. https:\/\/doi.org\/10.1111\/j.1440-1746.2007.05182.x (2008).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"77416_CR55","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1172\/JCI75438","volume":"125","author":"X Fu","year":"2015","unstructured":"Fu, X. et al. MicroRNA-26a regulates insulin sensitivity and metabolism of glucose and lipids. J. Clin. Invest. 125, 2497\u20132509. https:\/\/doi.org\/10.1172\/JCI75438 (2015).","journal-title":"J. Clin. Invest."},{"key":"77416_CR56","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1016\/j.bbrc.2018.07.084","volume":"503","author":"KH Min","year":"2018","unstructured":"Min, K. H., Yang, W. M. & Lee, W. Saturated fatty acids-induced mir-424-5p aggravates insulin resistance via targeting insulin receptor in hepatocytes. Biochem. Biophys. Res. Commun. 503, 1587\u20131593. https:\/\/doi.org\/10.1016\/j.bbrc.2018.07.084 (2018).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"77416_CR57","doi-asserted-by":"publisher","first-page":"e22517","DOI":"10.1096\/fj.202200488R","volume":"36","author":"C Cui","year":"2022","unstructured":"Cui, C. et al. Exosomes derived from mesenchymal stem cells attenuate diabetic kidney disease by inhibiting cell apoptosis and epithelial-to-mesenchymal transition via miR-424-5p. FASEB J. 36, e22517. https:\/\/doi.org\/10.1096\/fj.202200488R (2022).","journal-title":"FASEB J."},{"key":"77416_CR58","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1007\/s10157-022-02241-w","volume":"26","author":"J Li","year":"2022","unstructured":"Li, J., Min, Y. & Zhao, Q. Circ_0000064 knockdown attenuates high glucose-induced proliferation, inflammation and extracellular matrix deposition of mesangial cells through miR-424-5p-mediated WNT2B inhibition in cell models of diabetic nephropathy. Clin. Exp. Nephrol. 26, 943\u2013954. https:\/\/doi.org\/10.1007\/s10157-022-02241-w (2022).","journal-title":"Clin. Exp. Nephrol."},{"key":"77416_CR59","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1186\/s13287-021-02332-7","volume":"12","author":"A Tamara","year":"2021","unstructured":"Tamara, A., Coulson, D. J., Latief, J. S., Bakhashab, S. & Weaver, J. U. Upregulated anti-angiogenic mir-424-5p in type 1 diabetes (model of subclinical cardiovascular disease) correlates with endothelial progenitor cells, CXCR1\/2 and other parameters of vascular health. Stem Cell. Res. Ther. 12, 249. https:\/\/doi.org\/10.1186\/s13287-021-02332-7 (2021).","journal-title":"Stem Cell. Res. Ther."},{"key":"77416_CR60","doi-asserted-by":"publisher","first-page":"6208","DOI":"10.26355\/eurrev_202110_26991","volume":"25","author":"T Cheng","year":"2021","unstructured":"Cheng, T. et al. LINC00205, a YY1-modulated lncRNA, serves as a sponge for miR-26a-5p facilitating the proliferation of hepatocellular carcinoma cells by elevating CDK6. Eur. Rev. Med. Pharmacol. Sci. 25, 6208\u20136219. https:\/\/doi.org\/10.26355\/eurrev_202110_26991 (2021).","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"77416_CR61","doi-asserted-by":"publisher","first-page":"10708","DOI":"10.26355\/eurrev_201912_19771","volume":"23","author":"ML Li","year":"2019","unstructured":"Li, M. L., Zhang, Y. & Ma, L. T. LncRNA HCG11 accelerates the progression of hepatocellular carcinoma via miR-26a-5p\/ATG12 axis. Eur. Rev. Med. Pharmacol. Sci. 23, 10708\u201310720. https:\/\/doi.org\/10.26355\/eurrev_201912_19771 (2019).","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"77416_CR62","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1038\/s41419-018-0882-5","volume":"9","author":"Y Li","year":"2018","unstructured":"Li, Y. et al. Long non-coding RNA SNHG5 promotes human hepatocellular carcinoma progression by regulating miR-26a-5p\/GSK3beta signal pathway. Cell. Death Dis. 9, 888. https:\/\/doi.org\/10.1038\/s41419-018-0882-5 (2018).","journal-title":"Cell. Death Dis."},{"key":"77416_CR63","doi-asserted-by":"publisher","first-page":"3013","DOI":"10.2147\/CMAR.S237752","volume":"12","author":"WJ Zhu","year":"2020","unstructured":"Zhu, W. J., Yan, Y., Zhang, J. W., Tang, Y. D. & Han, B. Effect and mechanism of miR-26a-5p on proliferation and apoptosis of Hepatocellular Carcinoma cells. Cancer Manag Res. 12, 3013\u20133022. https:\/\/doi.org\/10.2147\/CMAR.S237752 (2020).","journal-title":"Cancer Manag Res."},{"key":"77416_CR64","doi-asserted-by":"publisher","first-page":"e2540","DOI":"10.1038\/cddis.2016.461","volume":"8","author":"F Jin","year":"2017","unstructured":"Jin, F. et al. MiR-26 enhances chemosensitivity and promotes apoptosis of hepatocellular carcinoma cells through inhibiting autophagy. Cell. Death Dis. 8, e2540. https:\/\/doi.org\/10.1038\/cddis.2016.461 (2017).","journal-title":"Cell. Death Dis."},{"key":"77416_CR65","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/s41419-019-2188-7","volume":"11","author":"Y Lin","year":"2020","unstructured":"Lin, Y. et al. Long non-coding RNA DLGAP1-AS1 facilitates tumorigenesis and epithelial-mesenchymal transition in hepatocellular carcinoma via the feedback loop of miR-26a\/b-5p\/IL-6\/JAK2\/STAT3 and Wnt\/beta-catenin pathway. Cell. Death Dis. 11, 34. https:\/\/doi.org\/10.1038\/s41419-019-2188-7 (2020).","journal-title":"Cell. Death Dis."},{"key":"77416_CR66","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1038\/s41419-020-02839-6","volume":"11","author":"Z Wang","year":"2020","unstructured":"Wang, Z. et al. ARNTL2 promotes pancreatic ductal adenocarcinoma progression through TGF\/BETA pathway and is regulated by miR-26a-5p. Cell. Death Dis. 11, 692. https:\/\/doi.org\/10.1038\/s41419-020-02839-6 (2020).","journal-title":"Cell. Death Dis."},{"key":"77416_CR67","doi-asserted-by":"publisher","first-page":"117035","DOI":"10.1016\/j.lfs.2019.117035","volume":"239","author":"L Tian","year":"2019","unstructured":"Tian, L., Zhao, Z. F., Xie, L. & Zhu, J. P. Taurine up-regulated 1 accelerates tumorigenesis of colon cancer by regulating miR-26a-5p\/MMP14\/p38 MAPK\/Hsp27 axis in vitro and in vivo. Life Sci. 239, 117035. https:\/\/doi.org\/10.1016\/j.lfs.2019.117035 (2019).","journal-title":"Life Sci."},{"key":"77416_CR68","doi-asserted-by":"publisher","first-page":"6955","DOI":"10.1038\/s41598-022-08091-6","volume":"12","author":"YH Chung","year":"2022","unstructured":"Chung, Y. H. et al. MiR-26a-5p as a useful therapeutic target for upper tract urothelial carcinoma by regulating WNT5A\/beta-catenin signaling. Sci. Rep. 12, 6955. https:\/\/doi.org\/10.1038\/s41598-022-08091-6 (2022).","journal-title":"Sci. Rep."},{"key":"77416_CR69","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1080\/14728222.2023.2293750","volume":"27","author":"W Zhang","year":"2023","unstructured":"Zhang, W. et al. miR-26a-5p restoration via EZH2 silencing blocks the IL-6\/STAT3 axis to repress the growth of prostate cancer. Expert Opin. Ther. Targets. 27, 1285\u20131297. https:\/\/doi.org\/10.1080\/14728222.2023.2293750 (2023).","journal-title":"Expert Opin. Ther. Targets"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-77416-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-77416-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-77416-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T09:06:14Z","timestamp":1731402374000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-77416-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,12]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["77416"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-77416-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,12]]},"assertion":[{"value":"5 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All research was conducted in accordance with the Declarations of Helsinki. The research experimental procedure was approved by the Ethics Committee of the Fundeni Clinical Institute (51715\/27.09.2022).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All enrolled patients gave written informed consent.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"27678"}}